Search Within

Efsevia Vakiani

  1. "Early Drug Development Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (12)
  2. Department of Pathology and Laboratory Medicine (12)
  3. Early Drug Development Service (12)
  4. GSK Faculty (12)
  5. Gastrointestinal Oncology Service (12)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. David Hyman (12)
  2. David Solit (12)
  3. Michael Berger (11)
  4. Jaclyn Hechtman (10)
  5. Ahmet Zehir (9)
  6. Marc Ladanyi (9)

More People

Years
  1. 2020 (1)
  2. 2018 (4)
  3. 2017 (2)
  4. 2016 (1)
  5. 2015 (4)
Publications
  1. Journal of Clinical Oncology (3)
  2. Annals of Oncology (1)
  3. Cancer Cell (1)
  4. Cancer Discovery (1)
  5. Cancer Research (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Nature Publishing Group (2)
  4. American Medical Association (1)
  5. Cell Press (1)
  6. Nature Research (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of genome-derived tumor type prediction to inform clinical cancer care
    Journal Article

    Penson, A.; Camacho, N.; Zheng, Y.; Varghese, A. M.; Al-Ahmadie, H.; Razavi, P.; Chandarlapaty, S.; Vallejo, C. E.; Vakiani, E.; Gilewski, T.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Clinical sequencing defines the genomic landscape of metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Chatila, W. K.; Lipsyc, M. D.; Hechtman, J. F.; Cercek, A.; Sanchez-Vega, F.; Jayakumaran, G.; Middha, S.; Zehir, A.; Donoghue, M. T. A.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Identification of targetable kinase alterations in patients with colorectal carcinoma that are preferentially associated with wild-type RAS/RAF
    Journal Article

    Hechtman, J. F.; Zehir, A.; Yaeger, R.; Wang, L.; Middha, S.; Zheng, T.; Hyman, D. M.; Solit, D.; Arcila, M. E.; Borsu, L.; more...
    Molecular Cancer Research (2016)

    Fulltext@MSK | Save
  • Prospective identification of potentially actionable molecular alterations in cancers of unknown primary
    Meeting Abstract

    Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save